ACAD
ACADIA Pharmaceuticals Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +11.1% ·
aandelenstroom +4.9% ·
netto nieuwe posities +10.0%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 122 | +9 | 91.00M | $2.30B | +11 | −1 |
| Q1 2026 | 115 | -3 | 85.30M | $1.90B | +4 | −8 |
| Q4 2025 | 119 | 0 | 93.96M | $2.51B | +1 | — |
| Q3 2025 | 23 | +1 | 66.53M | $1.42B | +1 | −1 |
| Q2 2025 | 20 | +2 | 61.51M | $1.33B | +2 | — |
| Q1 2025 | 15 | 0 | 22.54M | $374.41M | — | — |
| Q4 2024 | 15 | +1 | 20.32M | $372.93M | +1 | — |
| Q3 2024 | 13 | -1 | 13.63M | $209.57M | — | −1 |
| Q2 2024 | 14 | — | 19.35M | $314.37M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 20.65M | — | $445.47M | 0.0% | n/c | 1 | SEC ↗ ×15 |
| 2 | The Vanguard Group ✦ (passief) | 15.26M | — | $329.25M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passief) | 6.18M | -11.7% | $133.26M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Point72 Asset Management ✦ | 3.17M | -31.7% | $68.43M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passief) | 3.02M | +2.4% | $65.24M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | Citadel Advisors ✦ | 3.01M | +922.4% | $64.98M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Marshall Wace ✦ | 1.97M | +496.2% | $42.49M | 0.1% | ▲ Add | 5 | SEC ↗ ×3 |
| 8 | D. E. Shaw & Co. ✦ | 1.96M | -16.4% | $42.37M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 9 | Renaissance Technologies ✦ | 1.55M | +4.8% | $33.38M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 10 | Norges Bank ✦ (passief) | 1.47M | +3.4% | $31.68M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 928.75K | +43.0% | $20.03M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 12 | Adage Capital Partners ✦ | 603.80K | Nieuw | $13.02M | 0.0% | New | 1 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 483.10K | -40.8% | $10.42M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 14 | Arrowstreet Capital ✦ | 336.44K | Nieuw | $7.26M | 0.0% | New | 1 | SEC ↗ |
| 15 | Fisher Asset Management ✦ | 310.31K | -12.6% | $6.69M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 291.70K | +331.1% | $6.29M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 17 | Fidelity (FMR) ✦ | 169.36K | — | $3.65M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 18 | Millennium Management ✦ | 68.92K | -29.6% | $1.49M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | Wellington Management ✦ | 49.60K | -4.2% | $1.07M | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 20 | Gotham Asset Management ✦ | 17.61K | -48.3% | $379,783 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Adage Capital Partners | $13.02M | 0.0% |
| Arrowstreet Capital | $7.26M | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 337 houders, 164.47M aandelen, $3.62B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.